Revolution Medicines (RVMD) Assets Average (2020 - 2026)

Revolution Medicines' Assets Average history runs 7 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• In Q1 2026, Assets Average fell 6.41% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $2.3 billion (down 6.41% YoY), while the FY2025 annual figure was $2.5 billion, up 6.34% from the prior year.
• Assets Average was $2.3 billion for Q1 2026 at Revolution Medicines, roughly flat from $2.3 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.5 billion in Q1 2025 to a low of $657.8 million in Q2 2022.
• Historically, Assets Average has averaged $1.6 billion across 5 years, with a median of $1.8 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets Average dropped 17.03% in 2022, then jumped 110.59% in 2024.
• A 5-year view of Assets Average shows it stood at $818.9 million in 2022, then jumped by 85.97% to $1.5 billion in 2023, then soared by 41.87% to $2.2 billion in 2024, then climbed by 6.6% to $2.3 billion in 2025, then climbed by 0.04% to $2.3 billion in 2026.
• The last three Assets Average figures came in at $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.3 billion (Q3 2025), per Business Quant data.